| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |